查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1406902

海洋生物技術：市場佔有率分析、產業趨勢/統計、成長預測，2024-2029

Marine Biotechnology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

海洋生物技術市場預計在預測期內複合年成長率為8.5%。

COVID-19大流行影響了海洋生物技術產業的階段需求和生產。同時，這場大流行支持了海洋補充品的生產，因為它們可以提供 COVID-19 感染的潛在健康益處。例如，根據 2022 年 2 月發表在《抗氧化劑雜誌》上的一篇論文，幾種海藻物種被用作具有潛在抗病毒和免疫調節作用的生物活性代謝物。因此，在大流行期間，海洋補充品的使用量激增，極大地影響了市場成長。然而，隨著COVID-19感染數量的下降，海洋生物技術市場穩定成長，預計在預測期內也將出現類似的成長。

海洋生物技術-市場-IMG1

藻類和真菌等海洋生物在藥品、化妝品、食品、農業等各行業的使用量不斷增加，是推動海洋生物技術市場成長的主要因素。例如，2021年7月，印度國家海洋技術研究所的一群科學家借助深海細菌開發了一種用於製作化妝品的抗老化成分。此外，美國、德國和英國等已開發國家對海洋營養補充的需求食品增加。根據2022年2月發表在《海洋科學前沿雜誌》上的一篇論文，已知某些在惡劣環境條件下繁衍生息的海洋微生物含有抗氧化、抗菌、凋亡、抗腫瘤和抗病毒物質，可用於生產機能性食品成分用於維持健康及預防慢性疾病。在食品營養補充生產中增加利用海洋資源預計將在預測期內推動市場成長。此外，建議嬰兒和嬰幼兒攝取高水平的多元不用餐多不飽和脂肪酸。這些健康的脂肪酸是由海洋微藻類大量產生的。漁業、藥物研發和水產養殖領域的進步，以及人們對海洋生物開拓的潛力及其在各行業中的應用的日益認知，預計將很快增加對海洋生物技術來源的需求。

然而，缺乏海洋探勘以及在實驗室條件下培養海洋微生物的能力有限可能會限制預測期內的市場成長。

海洋生物技術市場趨勢

醫療與製藥部門預計在預測期內將顯著成長

在分析期間，醫療和製藥領域預計將佔據重要的市場佔有率。微生物源藥物現在擴大用於治療感染疾病和慢性病。最常用的微生物製劑有青黴素、放線菌素、頭孢菌素、鏈黴素和Cyclosporine。

增加與利用海洋生物生產針對各種疾病的各種治療藥物相關的研究活動預計將促進該領域的成長。例如，2021 年 1 月，加州大學的科學家在海洋環境中發現了結構多樣的天然化合物。這些化合物預計可用於開發抗病毒療法。此外，根據 2022 年 3 月發表在《醫療保健生物技術》雜誌上的一項研究，海藻具有近 11,000 種具有營養和藥理特性的天然益處。從微藻類和大型藻類中發現的許多化合物具有重要的藥理特性，例如抗菌、抗真菌、抗病毒、抗皰疹、抗氧化和降血糖特性。

科技進步提高了我們養殖海洋生物的能力。例如，2021年4月，日本科學家首次成功培育出穩定的珊瑚細胞株。這些進步和在製藥工業中使用海洋生物的研究活動的增加預計將為從海洋生物生產各種生醫材料開闢新的途徑。反過來，這可能會推動醫療和製藥業對海洋生物技術的需求。

海洋生物技術-市場-IMG2

預計在預測期內歐洲將佔據海洋生物技術市場的主要佔有率

預計歐洲將在整個預測期內佔據重要的市場佔有率。政府對促進天然海鮮產品利用的支持以及這些產品市場開拓資金籌措將支持預測期內德國市場的成長。例如，2021 年 3 月，德國生技公司 Bluu Biosciences 獲得了約 700 萬歐元（780 萬美元）的資金，用於利用細胞培養生產高品質、永續的魚產品。

先進的醫療基礎設施、海洋生物技術的進步以及製藥和化妝品行業對海洋生物不斷成長的需求是歐洲對海洋生物技術的高需求背後的主要因素。例如，2021年3月，Sea4Us計劃借助海洋生物製品開發一種非鴉片類鎮痛藥的慢性疼痛治療​​方法。該公司參與了歐盟委員會支持的多個計劃。

因此，上述因素以及歐洲大規模海水養殖業務預計將推動歐洲市場的成長。

海洋生物技術產業概況

海洋生物技術市場競爭中等，由多家大公司組成，例如BASF SE、AstaReal、Aker Biomarine、Euglena、Cyanotech Corporation 和 Earthrise Nutritionals LLC。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 製藥和化妝品行業更多地使用海洋生物
    • 對海洋營養補充食品的需求不斷增加
    • 漁業和藥物研發領域的進展
  • 市場抑制因素
    • 缺乏海洋探勘
    • 實驗室培養海洋微生物能力的限制
  • 波特五力分析
    • 供應商的議價能力
    • 買家/消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔

  • 按產地
    • 珊瑚和海綿
    • 藻類
    • 海洋病毒
    • 海洋真菌
    • 其他產地
  • 按最終用戶
    • 醫療/製藥
    • 食品工業
    • 化妝品產業
    • 化學工業
    • 其他最終用戶
  • 地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東/非洲
      • GCC
      • 南非
      • 其他中東/非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭形勢

  • 公司簡介
    • BASF SE
    • AstaReal Co., Ltd.
    • Aker Biomarine
    • Euglena Co.,Ltd.
    • Cyanotech Corporation
    • Earthrise Nutritionals LLC
    • CP Kelco US, Inc
    • Bluebiotech International GmbH
    • Marinomed Biotech AG
    • PharmaMar SA

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 72468
Marine Biotechnology - Market - IMG1

The marine biotechnology market is expected to register a CAGR of 8.5% over the forecast period.

The COVID-19 pandemic affected demand and production in the marine biotechnology industry during the initial phase. On the other hand, the pandemic aided the production of marine-derived supplements since they provided potential health benefits against the COVID-19 infection. For instance, as per the article published in the Journal of Antioxidants in February 2022, several marine algae species have been utilized for their bioactive metabolites with potential antiviral and immunomodulatory activities. Thus, the surging use of marine-derived supplements during the pandemic significantly impacted the market growth. However, with the decrease in number of COVID-19 cases, the marine biotechnology market has gained stable growth and is expected to do the same during the forecast period.

The increase in the usage of marine organisms, such as algae and fungi, in different industries, such as pharmaceuticals, cosmetics, food, and agriculture, is a major factor boosting the growth of the marine biotechnology market. For instance, in July 2021, a team of scientists from the National Institute of Ocean Technology, India, developed an anti-ageing ingredient for making cosmetics with the help of deep-sea bacteria. Furthermore, there is an increasing demand for marine-derived nutritional supplements in developed countries such as the United States, Germany, and the United Kingdom. According to an article published in the Journal of Frontiers in Marine Science in February 2022, certain marine microbes which thrive in harsh environmental conditions produce antioxidant, antibacterial, apoptotic, antitumoral, and antiviral chemicals, which could be used in the production of functional food ingredients for health maintenance and chronic disease prevention. The rise in the utilization of marine resources for the production of nutritional supplements is expected to add to the market's growth during the forecast period. Moreover, high dietary levels of polyunsaturated fatty acids are recommended for infants. These healthy fatty acids are produced in large quantities by marine microalgal species. Advancements in the fields of fisheries, drug discovery, and aquaculture and an increase in awareness regarding the untapped potential and use of marine organisms in different industries are expected to increase demand for marine biotechnology sources shortly.

However, the lack of exploration of the oceans and the limited ability to culture marine microorganisms in laboratory conditions will likely restrict the market's growth during the forecast period.

Marine Biotechnology Market Trends

The Medical and Pharmaceutical Segment is Expected to Register the Significant Growth Over the Forecast Period

The medical and pharmaceutical segment is anticipated to hold a significant market share over the analysis period. Currently, microbially derived drugs are increasingly being used in the treatment of infectious diseases and chronic diseases. The most commonly used microbially derived drugs are penicillin, actinomycin, cephalosporins, streptomycin, and cyclosporin.

The increase in research activities related to using marine organisms to produce different therapeutics for various diseases is expected to boost the segment's growth. For instance, in January 2021, scientists at the University of California identified structurally diverse natural compounds in the marine environment. These compounds are expected to help in the development of antiviral therapeutics. Moreover, according to the study published in Biotechnology in Healthcare Journal in March 2022, nearly 11,000 natural effects with nutrition and pharmacological properties have been reported in marine algae. Many compounds found in micro and macroalgae have critical pharmacological properties, such as antibacterial, antifungal, antiviral, antiherpetic, antioxidative, and hypoglycemic properties.

With the advancement in technology, the ability to culture marine organisms has improved. For instance, in April 2021, scientists in Japan successfully cultured the first stable coral cell lines. Such advancement and increased research activities related to using marine organisms in the pharmaceutical industry are expected to open new avenues for producing different biomaterials from marine organisms. This, in turn, can promote the demand for marine biotechnology in the medical and pharmaceutical industries.

Marine Biotechnology - Market - IMG2

Europe is Expected to Hold a Significant Share in the Marine Biotechnology Market Over the Forecast Period

Europe is expected to hold a significant market share throughout the forecast period. The government's support to promote the use of natural marine products and the availability of funding for developing these products will help boost the market growth in Germany during the forecast period. For instance, in March 2021, Bluu Biosciences, a German-based biotech firm, received almost EUR 7 million (USD 7.8 million) to produce high-quality, sustainable fish products from cell cultures.

The presence of sophisticated healthcare infrastructure, technological advancements in marine biotechnology, and the growing demand for marine organisms in the pharmaceutical and cosmetic industries are major factors for the high demand for marine biotechnology in Europe. For instance, in March 2021, Sea4Us planned on developing a remedy for chronic pain, a non-opioid analgesic, with the help of marine bioproducts. The company has worked on many European Commission-supported projects.

Hence, the factors mentioned above and the large marine-farming operations in Europe are expected to boost the market's growth in Europe.

Marine Biotechnology Industry Overview

The marine biotechnology market is moderately competitive and consists of a large number of major players, including BASF SE, AstaReal Co., Ltd., Aker Biomarine, Euglena Co., Ltd., Cyanotech Corporation, and Earthrise Nutritionals LLC, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Usage of Marine Organisms in the Pharmaceutical and Cosmetic Industries
    • 4.2.2 Increasing Demand for Marine-Derived Nutritional Supplements
    • 4.2.3 Advancements in the Field of Fisheries and Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Exploration in Oceans
    • 4.3.2 Limited Ability to Culture Marine Micro-organisms in Laboratories
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Source
    • 5.1.1 Corals and Sponges
    • 5.1.2 Algae
    • 5.1.3 Marine Viruses
    • 5.1.4 Marine Fungi
    • 5.1.5 Other Sources
  • 5.2 By End User
    • 5.2.1 Medical and Pharmaceutical
    • 5.2.2 Food Industry
    • 5.2.3 Cosmetics Industry
    • 5.2.4 Chemical Industry
    • 5.2.5 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 BASF SE
    • 6.1.2 AstaReal Co., Ltd.
    • 6.1.3 Aker Biomarine
    • 6.1.4 Euglena Co.,Ltd.
    • 6.1.5 Cyanotech Corporation
    • 6.1.6 Earthrise Nutritionals LLC
    • 6.1.7 CP Kelco U.S., Inc
    • 6.1.8 Bluebiotech International GmbH
    • 6.1.9 Marinomed Biotech AG
    • 6.1.10 PharmaMar SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS